J. Jay Lobell - 01 Jan 2026 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role: Director
Signature: /s/ Samuel Berry, Attorney-in-Fact
Issuer symbol: FBIO
Transactions as of: 01 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 05 Jan 2026, 16:30:26 UTC
Previous filing: 03 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LOBELL J JAY	Director	C/O FORTRESS BIOTECH, INC., 1111 KANE CONCOURSE SUITE 301, BAY HARBOR ISLANDS	/s/ Samuel Berry, Attorney-in-Fact	05 Jan 2026	0001172659

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FBIO	common stock, par value $0.001	Award	$0	+27,322	+17%	$0.000000	192,397	01 Jan 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.
F2	Total holdings include 76,705 shares underlying deferred restricted stock units.

Content

The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.

Total holdings include 76,705 shares underlying deferred restricted stock units.